Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
reduced decrease » reduced disease (Expand Search), reported decrease (Expand Search), induces decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
reduced decrease » reduced disease (Expand Search), reported decrease (Expand Search), induces decreased (Expand Search)
-
2041
T3SS induction slows growth, but cells can support high levels of S10 expression.
Published 2025Subjects: -
2042
-
2043
Full RNA-seq dataset: list of genes with heightened reads in stationary phase.
Published 2025Subjects: -
2044
Full RNA-seq dataset: list of genes with heightened reads in exponential phase.
Published 2025Subjects: -
2045
-
2046
Droplet-based microfluidics can be used to model clustered bacterial growth.
Published 2025Subjects: -
2047
S10 and T3SS reporter signals do not correlate in the absence of MgOx treatment.
Published 2025Subjects: -
2048
-
2049
-
2050
-
2051
Difference in
Published 2025“…Compared with the resting levels, the alpha/beta ratio of EEG (indicating relaxed concentration) was significantly decreased by 19% in the video-based VR and increased by 40% in the immersive VR groups (both p < 0.05). …”
-
2052
Experimental protocol.
Published 2025“…Compared with the resting levels, the alpha/beta ratio of EEG (indicating relaxed concentration) was significantly decreased by 19% in the video-based VR and increased by 40% in the immersive VR groups (both p < 0.05). …”
-
2053
Relationship between the change in
Published 2025“…Compared with the resting levels, the alpha/beta ratio of EEG (indicating relaxed concentration) was significantly decreased by 19% in the video-based VR and increased by 40% in the immersive VR groups (both p < 0.05). …”
-
2054
-
2055
Exclusion and enrollment summary from NHANES.
Published 2025“…Individuals under 30 showed no significant differences. A unit increase below 9.30 in Log2-PMR reduced HCV risk by 0.60-fold. …”
-
2056
-
2057
-
2058
Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration.
Published 2024“…<b>c</b> Further addition of bevacizumab to serum samples post-bevacizumab administration significantly decreased VEGF-A121 levels in samples to which 20 and 200 μg/mL bevacizumab was added (ANOVA: <i>p</i> < 0.0001; Dunnett’s multiple comparisons test: +2 μg/mL, <i>p</i> = 0.7096 vs control; +20 μg/mL, <i>p</i> = 0.0107 vs control; +200 μg/mL, <i>p</i> < 0.0001 vs control). …”
-
2059
-
2060
Anthelmintics Derived from the Kinase Inhibitor SGI-1776 for the Treatment of Gastrointestinal Worm Infections
Published 2025“…We demonstrate the efficacy of optimized compound <b>50</b> as a new oral anthelmintic, which demonstrated better gut restriction properties and significantly reduced the fecundity of T. muris whipworm adults in infected mice. …”